电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Peptidoglycan Recognition Protein 1 (PGLYRP1) (C-Term) Peptide

PGLYRP1 适用: 人 宿主: 合成 BP, WB
产品编号 ABIN5511437
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Peptidoglycan Recognition Protein 1 (PGLYRP1) (C-Term) Peptide (ABIN5511437)

抗原

PGLYRP1 (Peptidoglycan Recognition Protein 1 (PGLYRP1))

宿主

资源

  • 3
合成

应用范围

Blocking Peptide (BP), Western Blotting (WB)
  • 蛋白结构域

    C-Term

    序列

    TPQAIRAAQG LLACGVAQGA LRSNYVLKGH RDVQRTLSPG NQLYHLIQNW

    产品特性

    This is a synthetic peptide designed for use in combination with anti- PGLYRP1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    储存条件

    -20 °C

    储存方法

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • 抗原

    PGLYRP1 (Peptidoglycan Recognition Protein 1 (PGLYRP1))

    背景

    Pattern receptor that binds to murein peptidoglycans (PGN) of Gram-positive bacteria. Has bactericidal activity towards Gram-positive bacteria. May kill Gram-positive bacteria by interfering with peptidoglycan biosynthesis. Binds also to Gram-negative bacteria, and has bacteriostatic activity towards Gram-negative bacteria. Plays a role in innate immunity.

    Alias Symbols: PGRP, TAG7, PGRPS, PGLYRP, PGRP-S, TNFSF3L

    Protein Size: 196

    基因ID

    8993

    NCBI登录号

    NM_005091, NP_005082

    UniProt

    O75594
You are here: